Caenorhabditis elegans as a model system for human diseases

被引:72
|
作者
Markaki, Maria [1 ]
Tavernarakis, Nektarios [1 ,2 ]
机构
[1] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece
[2] Univ Crete, Sch Med, Dept Basic Sci, Iraklion 70013, Crete, Greece
基金
欧洲研究理事会;
关键词
ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CELL-DEATH; C-ELEGANS; TAU; AGGREGATION; GENETICS; SUSCEPTIBILITY; NEUROTOXICITY;
D O I
10.1016/j.copbio.2019.12.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The nematode Caenorhabditis elegans offers unique advantages that enable a comprehensive delineation of the cellular and molecular mechanisms underlying devastating human pathologies such as stroke, ischemia and age-associated neurodegenerative disorders. Genetic models of human diseases that closely simulate several disease-related phenotypes have been established in the worm. These models allow the implementation of multidisciplinary approaches, in addition to large-scale genetic and pharmacological screenings, designed to elucidate the molecular mechanisms mediating pathogenesis and to identify targets and drugs for emergent therapeutic interventions. Such strategies have already provided valuable insights, highly relevant to human health and quality of life. This article considers the potential of C. elegans as a versatile platform for systematic dissection of the molecular basis of human disease, focusing on neurodegenerative disorders.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 50 条
  • [31] Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans
    Wang, Yiru Anning
    Kammenga, Jan Edward
    Harvey, Simon Crawford
    HUMAN GENOMICS, 2017, 11
  • [32] Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans
    Yiru Anning Wang
    Jan Edward Kammenga
    Simon Crawford Harvey
    Human Genomics, 11
  • [33] Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases
    Rani, Nisha
    Alam, Mohammad Mumtaz
    Jamal, Azfar
    Bin Ghaffar, Usama
    Parvez, Suhel
    AGEING RESEARCH REVIEWS, 2023, 91
  • [34] Evaluation of Caenorhabditis elegans model for lysosomal diseases caused by deficits of glycosidases.
    Hrebicek, M
    Sikora, J
    Hujova, J
    Holanova, D
    Poupetova, H
    Asfaw, B
    Ledvinova, J
    Kostrouchova, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 348 - 348
  • [35] Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases
    Nussbaum-Krammer, Carmen I.
    Morimoto, Richard I.
    DISEASE MODELS & MECHANISMS, 2014, 7 (01) : 31 - 39
  • [36] Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies
    Bulger, David A.
    Fukushige, Tetsunari
    Yun, Sijung
    Semple, Robert K.
    Hanover, John A.
    Krause, Michael W.
    G3-GENES GENOMES GENETICS, 2017, 7 (01): : 257 - 268
  • [37] Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations
    Chauhan, Payal
    Wadhwa, Karan
    Singh, Govind
    FRONTIERS IN NANOTECHNOLOGY, 2022, 4
  • [38] Functional genomic approaches using the nematode Caenorhabditis elegans as a model system
    Lee, J
    Nam, S
    Hwang, SB
    Hong, MG
    Kwon, JY
    Joeng, KS
    Im, SH
    Shim, JW
    Park, MC
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 37 (01): : 107 - 113
  • [39] Caenorhabditis elegans as a model for obesity research
    Zheng, J.
    Greenway, F. L.
    INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (02) : 186 - 194
  • [40] Caenorhabditis elegans as a model for cancer research
    Kyriakakis, Emmanouil
    Markaki, Maria
    Tavernarakis, Nektarios
    MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (02):